Search
for
Sort by
Research 301–330 of 1000+
- Successful treatment of resistant alopecia totalis with tofacitinib
- Treatment of Lichen Planopilaris and Frontal Fibrosing Alopecia: A Retrospective, Real-Life Analysis in a Tertiary Center in Germany
- LB1012 The development of a pediatric alopecia areata treatment classification system based on results from a systematic review
- What’s new in the treatment of hair loss?
- Aim to alleviate alopecia areata with newly available agents
- Novel investigational drugs for alopecia areata and future perspectives
- Precision Dermatology: A Review of Molecular Biomarkers and Personalized Therapies
- Hairy tongue associated with the use of baricitinib therapy for ophiasis pattern alopecia areata
- Clinical guidelines of ukrainian hair research society. diagnosis and treatment of alopecia areata
- Advances in the mechanism and new therapies of alopecia areata
- A superb way to split hairs
- Survey of pediatric dermatologist views on treatment for alopecia areata
- Treatment modalities for lymphocytic and neutrophilic scarring alopecia
- An Updated in the Management of Alopecia Areata
- Androgenetic alopecia: An update
- Markers of Venous Thromboembolism Risk in Patients with Alopecia Areata: Is There Anything to Worry about?
- Treatment Patterns and Unmet Needs in the Management of Alopecia Areata: Results of a Physician’s Survey in the Middle East
- Overview of alopecia areata for managed care and payer stakeholders in the United States
- Systemic immunotherapies
- 504 A single-center retrospective study evaluating the efficacy of intravenous methylprednisolone pulse therapy for 113 patients with alopecia areata
- Alopecia areata in children: an overview of clinical features and recent treatment options
- 013 IL-15/IL-15Rα signaling is a guardian of human hair follicle immune privilege and promotes hair growth
- Common Causes of Hair Loss
- P100: Efficacy of current treatments under study in patients with alopecia areata
- Alopecia areata: a review of diagnosis, pathogenesis and the therapeutic landscape
- 22-Year-Old Male with Several Discrete Patches of Hair Loss
- DataSheet2_Vitiligo: An Autoimmune Skin Disease and its Immunomodulatory Therapeutic Intervention.PDF
- DataSheet1_Vitiligo: An Autoimmune Skin Disease and its Immunomodulatory Therapeutic Intervention.PDF
- Reply to early onset effluvium secondary to COVID-19 and body-hair effluvium
- The changing landscape of managing hair loss: a 30‐year perspective